Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05922202 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Influence of Frailty on Cardiovascular Events and Mortality in Patients With COPD.

Study acronym: FrCVCOPD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 5, 2025 (before its estimated November 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv5
  2. Study description expanded, about 12 words
    • Eligibility criteria shortened, about 4 words
    v4
  3. Study description expanded, about 22 wordsv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 25, 2023 to Feb 23, 2024
    • Primary completion date: Sep 25, 2025 to Nov 15, 2025
    • Collaborators expanded, about 24 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Observational study on the influence of frailty on cardiovascular risk in COPD.
Trial Details
NCT Number NCT05922202
Lead Sponsor Azienda Ospedaliero-Universitaria di Modena
Collaborators: Campus Bio-Medico University, Ospedale Sant'Andrea - Azienda Sanitaria Locale di Vercelli-Reparto di Pneumologia, Hospitals - Aneurin Bevan University Heath Board (Wales) - United Kingdom
Conditions
(from sponsor)		 Role of Frailty in COPD
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov